Table 2.
All-cause deaths (N=1064) | Breast cancer deaths (N=828) | |||
---|---|---|---|---|
Baseline variable | No. | RR(95% CI) | No. | RR(95% CI) |
OC use status | ||||
Never | 255 | 1.00 | 172 | 1.00 |
Ever | 809 | 1.01(0.86–1.19) | 656 | 1.03(0.85–1.25) |
Former | 767 | 1.01(0.86–1.19) | 616 | 1.03(0.85–1.24) |
Current | 41 | 0.89(0.62–1.28) | 39 | 0.95(0.65–1.40) |
OC use duration (years) | ||||
<1 | 187 | 0.94(0.77–1.15) | 142 | 0.92(0.73–1.17) |
1–<5 | 295 | 1.17(0.97–1.41) | 230 | 1.15(0.93–1.43) |
5–<10 | 180 | 0.97(0.78–1.19) | 154 | 1.02(0.80–1.29) |
≥10 | 147 | 0.93(0.74–1.16) | 130 | 1.00(0.78–1.28) |
P-trend | 0.52 | 0.35 | ||
Age at first OC use (years) | ||||
<20 | 324 | 1.01(0.82–1.24) | 283 | 1.06(0.84–1.35) |
20–24 | 264 | 0.97(0.80–1.18) | 220 | 1.01(0.81–1.27) |
25–29 | 136 | 1.03(0.83–1.28) | 92 | 0.93(0.71–1.22) |
≥30 | 84 | 1.06(0.82–1.36) | 60 | 1.09(0.81–1.47) |
Years between last OC use and breast cancer diagnosis | ||||
≥25 | 236 | 1.11(0.92–1.34) | 175 | 1.12(0.90–1.41) |
20–24 | 191 | 1.01(0.82–1.23) | 145 | 0.97(0.77–1.24) |
10–<20 | 250 | 0.94(0.76–1.15) | 216 | 1.00(0.80–1.27) |
<10 | 131 | 0.82(0.64–1.06) | 119 | 0.87(0.65–1.15) |
Years between menarche and first OC use | ||||
<9 | 408 | 1.01(0.83–1.23) | 355 | 1.06(0.85–1.33) |
9–<15 | 253 | 0.95(0.79–1.15) | 198 | 0.97(0.77–1.21) |
≥15 | 147 | 1.08(0.88–1.33) | 102 | 1.05(0.82–1.35) |
Years of OC use before first full-term pregnancy (FFTP) | ||||
1st OC use after FFTP | 396 | 1.01(0.86–1.20) | 314 | 1.05(0.86–1.29) |
No FFTP | 125 | 1.06(0.84–1.35) | 89 | 0.90(0.68–1.20) |
<3 | 61 | 0.89(0.66–1.21) | 51 | 0.89(0.63–1.25) |
3–<6 | 98 | 1.09(0.84–1.41) | 88 | 1.15(0.86–1.52) |
≥6 | 125 | 0.94(0.74–1.21) | 110 | 0.96(0.73–1.27) |
Calendar year of first OC use | ||||
<1972 | 544 | 1.05(0.89–1.24) | 421 | 1.07(0.88–1.31) |
≥1973 | 264 | 0.87(0.69–1.09) | 234 | 0.87(0.67–1.13) |
Total number of deaths may vary due to missing values in corresponding variables. All models use age (in days) as the time metric and stratify on age (in years) at breast cancer diagnosis. Covariates included in the models are study site, race, estrogen receptor status, tumor stage, education level, smoking status, alcohol consumption, number of comorbidities, number of mammograms within the 5 years before breast cancer diagnosis, body mass index 5 years before cancer diagnosis, and age at menarche.